Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Stage

Series A | Alive

Total Raised

$11M

Valuation

$0000 

Last Raised

$11M | 14 yrs ago

About Bikam Pharmaceuticals

BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, there are approximately 1.5 million people which suffer from retinitis pigmentosa (RP), a hereditary disease which leads to blindness. As its initial priority, the company is pursuing the discovery of compounds based on a novel mechanism of action identified by the company's founder, Dr. Shalesh Kaushal. BIKAM has an experienced management team with a strong track record in pharmaceutical drug discovery dedicated to expanding these findings and others from the Kaushal lab to create potential therapeutics to prevent blindness.

Bikam Pharmaceuticals Headquarter Location

55 Cambridge Parkway Suite 301

Cambridge, Massachusetts, 02142,

United States

617-252-4343

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bikam Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bikam Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

818 items

Bikam Pharmaceuticals Patents

Bikam Pharmaceuticals has filed 11 patents.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Disorders of choroid and retina
  • G protein coupled receptors
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/29/2012

8/7/2018

Diseases of the eye and adnexa, G protein coupled receptors, Vision, Ophthalmology, Transcription factors

Grant

Application Date

11/29/2012

Grant Date

8/7/2018

Title

Related Topics

Diseases of the eye and adnexa, G protein coupled receptors, Vision, Ophthalmology, Transcription factors

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.